These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 33739299)
21. Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis-Impact of Valve Size in a Single Center Experience. Wöhrle J; Gonska B; Rodewald C; Seeger J; Scharnbeck D; Rottbauer W PLoS One; 2016; 11(3):e0151247. PubMed ID: 27003573 [TBL] [Abstract][Full Text] [Related]
22. Predictors for low TAVI-prosthesis position assessed by fusion imaging of pre- and post-procedural CT angiography. Breitbart P; Pache G; Minners J; Hein M; Schröfel H; Neumann FJ; Ruile P Clin Res Cardiol; 2021 Jan; 110(1):93-101. PubMed ID: 32399896 [TBL] [Abstract][Full Text] [Related]
23. Latest-iteration balloon- and self-expandable transcatheter valves for severe bicuspid aortic stenosis: the TRITON study. Amat-Santos IJ; García-Gómez M; de Marco F; Won-Keun K; Brito J; Halim J; Jose J; Sengotuvelu G; Seth A; Terkelsen C; Protasiewicz M; Bonilla N; García B; Sánchez-Luna JP; Blasco-Turrión S; González JC; González-Bartol E; Ijsselmuiden AJJ; Gómez-Salvador I; Carrasco Moraleja M; San Román A Rev Esp Cardiol (Engl Ed); 2023 Nov; 76(11):872-880. PubMed ID: 36898524 [TBL] [Abstract][Full Text] [Related]
24. Do CTA measurements of annular diameter, perimeter and area result in different TAVI prosthesis sizes? Horehledova B; Mihl C; Hendriks BMF; Eijsvoogel NG; Vainer J; Veenstra LF; Wildberger JE; Das M Int J Cardiovasc Imaging; 2018 Nov; 34(11):1819-1829. PubMed ID: 29909590 [TBL] [Abstract][Full Text] [Related]
25. Transfemoral aortic valve implantation is more successful with the Edwards Sapien 3 compared with the Edwards XT for the treatment of symptomatic severe aortic stenosis. Gonska B; Seeger J; Junker A; Rodewald C; Trepte U; Scharnbeck D; Rottbauer W; Wöhrle J Arch Cardiovasc Dis; 2018; 111(8-9):470-479. PubMed ID: 29128473 [TBL] [Abstract][Full Text] [Related]
26. SAVR versus TAVI: What about the Hemodynamic Performance? An In Vivo and In Vitro Analysis. Eghbalzadeh K; Rahmanian PB; Giese D; Kuhn EW; Djordjevic I; Kaya S; Weber C; Baldus S; Mader N; Wahlers TCW Thorac Cardiovasc Surg; 2020 Oct; 68(7):608-615. PubMed ID: 31505690 [TBL] [Abstract][Full Text] [Related]
32. Successful transapical implantation of an Edwards Sapien valve within an insufficient aortic CoreValve prosthesis: an initial experience. Schleger S; Kasel M; Vogel J; Lieber M; Antoni D; Hoffmann E; Eichinger WB Ann Thorac Surg; 2013 Mar; 95(3):1070-2. PubMed ID: 23438533 [TBL] [Abstract][Full Text] [Related]
33. Outcomes of three different new generation transcatheter aortic valve prostheses. Costa G; Buccheri S; Barbanti M; Picci A; Todaro D; Di Simone E; La Spina K; D'Arrigo P; Criscione E; Nastasi M; Sgroi C; Tamburino C Catheter Cardiovasc Interv; 2020 Feb; 95(3):398-407. PubMed ID: 31609073 [TBL] [Abstract][Full Text] [Related]
34. A prospective "oversizing" strategy of the Edwards SAPIEN bioprosthesis: results and impact on aortic regurgitation. Samim M; Stella PR; Agostoni P; Kluin J; Ramjankhan F; Sieswerda G; Budde R; van der Linden M; Juthier F; Banfi C; Hurt C; Samim M; Hillaert M; van Herwerden L; Bertrand ME; Doevendans PA; Van Belle E J Thorac Cardiovasc Surg; 2013 Feb; 145(2):398-405. PubMed ID: 22377664 [TBL] [Abstract][Full Text] [Related]
36. Effect of oversizing and elliptical shape of aortic annulus on transcatheter valve hemodynamics: An in vitro study. Salaun E; Zenses AS; Evin M; Collart F; Habib G; Pibarot P; Rieu R Int J Cardiol; 2016 Apr; 208():28-35. PubMed ID: 26826627 [TBL] [Abstract][Full Text] [Related]
37. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR. Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318 [TBL] [Abstract][Full Text] [Related]
38. Early clinical outcome of aortic transcatheter valve-in-valve implantation in the Nordic countries. Ihlberg L; Nissen H; Nielsen NE; Rück A; Busund R; Klaarborg KE; Soendergaard L; Harnek J; Miettinen H; Eskola M; Wahba A; Laine M J Thorac Cardiovasc Surg; 2013 Nov; 146(5):1047-54; discussion 1054. PubMed ID: 23998786 [TBL] [Abstract][Full Text] [Related]
39. In-hospital and thirty-day outcomes of the SAPIEN 3 Ultra balloon-expandable transcatheter aortic valve: the S3U registry. Saia F; Gandolfo C; Palmerini T; Berti S; Doshi SN; Laine M; Marcelli C; Piva T; Ribichini F; De Benedictis M; Cardaioli F; Cannata S; Tarantini G EuroIntervention; 2020 Feb; 15(14):1240-1247. PubMed ID: 31763985 [TBL] [Abstract][Full Text] [Related]
40. Transapical transcatheter aortic valve implantation using a new second-generation TAVI system - J-Valve™ for high-risk patients with aortic valve diseases: Initial results with 90-day follow-up. Zhu D; Chen Y; Guo Y; Hu J; Zhang J; Wei X; Tang H; Shi Y Int J Cardiol; 2015 Nov; 199():155-62. PubMed ID: 26197402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]